JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 22, 2005; DOI: 10.1124/jpet.105.099044

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.099044v1
317/1/153    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, N. P.
Right arrow Articles by Richardson, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, N. P.
Right arrow Articles by Richardson, D. R.


Received for publication November 28, 2005.
Revised December 20, 2005.
Accepted for publication December 21, 2005.

RESISTANCE TO THE ANTI-NEOPLASTIC AGENT GALLIUM NITRATE RESULTS IN MARKED ALTERATIONS IN INTRACELLULAR IRON AND GALLIUM TRAFFICKING: IDENTIFICATION OF NOVEL INTERMEDIATES

Neil P. Davies 1, Yohan Suryo Rahmanto 1, Christopher R. Chitambar 2, Des R. Richardson 1*

1 Childrens Cancer Institute Australia for Medical Research 2 Medical College of Wisconsin

* Address correspondence to: E-mail: d.richardson{at}med.usyd.edu.au

Abstract

Gallium (Ga) shows significant anti-tumor activity by markedly interfering with iron (Fe) metabolism and 67Ga is used as a radio-imaging agent for cancer detection. Therefore, the mechanisms involved in 67Ga uptake, metabolism and resistance are critical to understand. The development of tumor lines that are Ga-resistant suggests 67Ga uptake may be different in these cells providing an opportunity for understanding intracellular 67Ga- and 59Fe-transport and Ga-resistance. In this study, Ga- resistant cells were used to assess 67Ga and 59Fe uptake using native-PAGE-autoradiography. In contrast to the common view that 67Ga and 59Fe use the same uptake pathways, we show that the trafficking of these two metal ions is different in cells either resistant (R) or sensitive (S) to Ga. Indeed, in contrast to 59Fe, little 67Ga is incorporated into ferritin, with most present as a labile 67Ga pool. We also report unique changes in 67Ga- and 59Fe-trafficking between R- and S-cells. In particular, in R-cells, there was a distinct transferrin- transferrin receptor 1-hemochromatosis protein (HFE) complex (band-B) not observed in S-cells. Furthermore, since HFE regulates Fe and Ga uptake, the two Tf-TfR1-HFE complexes in R-cells may be involved in reduced 67Ga and 59Fe uptake compared to S-cells. In S-cells, a novel Fe- binding intermediate (band-D) was identified that was not present in R-cells and may be a "sensitivity factor" to Ga. In contrast to the general view that 67Ga and 59Fe use the same or similar uptake pathways, we show that their distribution and trafficking is markedly different in R and S cells.


Key words: ferritin, gallium, iron, iron metabolism, transferrin, transferrin receptor


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
C. R. Chitambar, D. P. Purpi, J. Woodliff, M. Yang, and J. P. Wereley
Development of Gallium Compounds for Treatment of Lymphoma: Gallium Maltolate, a Novel Hydroxypyrone Gallium Compound, Induces Apoptosis and Circumvents Lymphoma Cell Resistance to Gallium Nitrate
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1228 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Yang, S. H. Kroft, and C. R. Chitambar
Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate
Mol. Cancer Ther., February 1, 2007; 6(2): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. R. Chitambar, J. P. Wereley, and S. Matsuyama
Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition.
Mol. Cancer Ther., November 1, 2006; 5(11): 2834 - 2843.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.